Evidence map›Paper›PMID 25383517›Full record

ArticleNature2014

Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Edward T Chouchani, Victoria R Pell, Edoardo Gaude, Dunja Aksentijević, Stephanie Y Sundier, Ellen L Robb, Angela Logan, Sergiy M Nadtochiy, Emily N J Ord, Anthony C Smith and 19 more

Abstract readComparative Study
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,631 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,631citing papers in PubMed, 1 pooled it
55.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,631 citing papers in PubMed, 1 synthesis or guideline pooled it, 2,713 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. A diagnostic accuracy study of mitochondrial FMN during hypothermic oxygenated perfusion to guide liver utilization and avoid normothermic assessment.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

1,571 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 2 countries.

Edward T Chouchani *MRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Victoria R Pell *Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Edoardo GaudeMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
Dunja AksentijevićKing's College London, British Heart Foundation Centre of Excellence, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK.
Stephanie Y SundierDepartment of Cell and Developmental Biology and UCL Consortium for Mitochondrial Biology, University College London, Gower Street, London WC1E 6BT, UK.
Ellen L RobbMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Angela LoganMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Sergiy M NadtochiyDepartment of Anesthesiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Emily N J OrdInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.
Anthony C SmithMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Filmon EyassuMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Rachel ShirleyInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.
Chou-Hui HuDepartment of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Anna J DareMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Andrew M JamesMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Sebastian RogattiMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Richard C HartleySchool of Chemistry, University of Glasgow, Glasgow, G12 8TA, UK.
Simon EatonUnit of Paediatric Surgery, UCL Institute of Child Health, London, WC1N 1EH, UK.
Ana S H CostaMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
Paul S BrookesDepartment of Anesthesiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Sean M DavidsonHatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
Michael R DuchenDepartment of Cell and Developmental Biology and UCL Consortium for Mitochondrial Biology, University College London, Gower Street, London WC1E 6BT, UK.
Kourosh Saeb-ParsyUniversity Department of Surgery and Cambridge NIHR Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Michael J ShattockKing's College London, British Heart Foundation Centre of Excellence, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK.
Alan J RobinsonMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
Lorraine M WorkInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.
Christian FrezzaMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
Thomas KriegDepartment of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Michael P MurphyMRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK.
MRC Mitochondrial Biology Unit · GBAddenbrooke's Hospital · GBUniversity College London · GBUniversity of Cambridge · GBUniversity of Glasgow · GBUniversity of Rochester Medical Center · USMRC Cancer Unit · GB

Funding

SIRT1, Nitro-Lipids and CardioprotectionR01HL071158 · NHLBI · UNIVERSITY OF ROCHESTER · PI BROOKES, PAUL S · 2003 to 2025
$7.7M
British Heart Foundation PG/07/126/24223British Heart Foundation PG/12/42/29655British Heart Foundation RG/12/4/29426CIHRMedical Research Council G1100562Medical Research Council MC_U105663142Medical Research Council MC_U105674181Medical Research Council MC_UP_1101/3Medical Research Council MC_UU_12022/6NHLBI NIH HHS R01 HL071158
6 · The paper itself

Abstract

Ischaemia-reperfusion injury occurs when the blood supply to an organ is disrupted and then restored, and underlies many disorders, notably heart attack and stroke. While reperfusion of ischaemic tissue is essential for survival, it also initiates oxidative damage, cell death and aberrant immune responses through the generation of mitochondrial reactive oxygen species (ROS). Although mitochondrial ROS production in ischaemia reperfusion is established, it has generally been considered a nonspecific response to reperfusion. Here we develop a comparative in vivo metabolomic analysis, and unexpectedly identify widely conserved metabolic pathways responsible for mitochondrial ROS production during ischaemia reperfusion. We show that selective accumulation of the citric acid cycle intermediate succinate is a universal metabolic signature of ischaemia in a range of tissues and is responsible for mitochondrial ROS production during reperfusion. Ischaemic succinate accumulation arises from reversal of succinate dehydrogenase, which in turn is driven by fumarate overflow from purine nucleotide breakdown and partial reversal of the malate/aspartate shuttle. After reperfusion, the accumulated succinate is rapidly re-oxidized by succinate dehydrogenase, driving extensive ROS generation by reverse electron transport at mitochondrial complex I. Decreasing ischaemic succinate accumulation by pharmacological inhibition is sufficient to ameliorate in vivo ischaemia-reperfusion injury in murine models of heart attack and stroke. Thus, we have identified a conserved metabolic response of tissues to ischaemia and reperfusion that unifies many hitherto unconnected aspects of ischaemia-reperfusion injury. Furthermore, these findings reveal a new pathway for metabolic control of ROS production in vivo, while demonstrating that inhibition of ischaemic succinate accumulation and its oxidation after subsequent reperfusion is a potential therapeutic target to decrease ischaemia-reperfusion injury in a range of pathologies.

Indexed as

Adenosine MonophosphateAnimalsAspartic AcidCitric Acid CycleDisease Models, AnimalElectron TransportElectron Transport Complex IFumaratesIschemiaMalatesMaleMetabolomicsMiceMitochondriaMyocardial InfarctionMyocardiumAdenosine MonophosphateAspartic AcidElectron Transport Complex IFumaratesfumaric acidMalatesmalic acidNADReactive Oxygen SpeciesSuccinate DehydrogenaseSuccinic Acid

Identifiers

PMID25383517
PMCPMC4255242
OpenAlexW2122091775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.